Gain Therapeutics, Inc. (GANX) is trading at $1.83 up 3.69% over the past 24 hours. Its Galaxy Score is 68.4, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 1K engagements and 18 posts with 93% positive social sentiment.
AI summary: Gain Therapeutics GT-02287 IND clearance advances to Phase 2 for Parkinson's disease. Positive IND news sparks optimism but near-term selling pressure and liquidity/dilution concerns likely cap upside, keeping GANX range-bound.
Gain Therapeutics, Inc. (GANX) is tracked on LunarCrush, where you can follow its price alongside live social activity and sentiment across X, Reddit, YouTube and other networks.
Gain Therapeutics, Inc. (GANX) is trading at $1.83, up 3.69% over the past 24 hours.
$GANX has a Galaxy Score of 68.4 — LunarCrush's 0–100 measure combining an asset's market and social performance.
Yes. $GANX social sentiment is 93% positive across social posts over the last 24 hours.
There have been 18 posts about $GANX over the last 24 hours.
On LunarCrush — follow $GANX's real-time social sentiment, engagement and market activity across X, Reddit, YouTube, TikTok and news in one place.